Xiaodan Xu

2.7k total citations · 1 hit paper
136 papers, 1.9k citations indexed

About

Xiaodan Xu is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Xiaodan Xu has authored 136 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Surgery, 36 papers in Pulmonary and Respiratory Medicine and 34 papers in Molecular Biology. Recurrent topics in Xiaodan Xu's work include Nanoplatforms for cancer theranostics (15 papers), Pediatric Hepatobiliary Diseases and Treatments (12 papers) and Gallbladder and Bile Duct Disorders (12 papers). Xiaodan Xu is often cited by papers focused on Nanoplatforms for cancer theranostics (15 papers), Pediatric Hepatobiliary Diseases and Treatments (12 papers) and Gallbladder and Bile Duct Disorders (12 papers). Xiaodan Xu collaborates with scholars based in China, New Zealand and Germany. Xiaodan Xu's co-authors include Kun Ren, Youqing Shen, Jianbin Tang, Ebrahim Haroon, Neeti D. Mehta, Jennifer C. Felger, Zhihao Li, Zhuxian Zhou, Nigel K.H. Slater and Feifei Li and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaodan Xu

125 papers receiving 1.9k citations

Hit Papers

The mechanisms of ferroptosis and its role in atheroscler... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaodan Xu China 24 679 376 276 251 238 136 1.9k
Yawei Zhao China 28 943 1.4× 354 0.9× 227 0.8× 124 0.5× 219 0.9× 61 2.3k
Hongmei Liu China 29 1.4k 2.1× 437 1.2× 189 0.7× 249 1.0× 126 0.5× 127 2.8k
Danyang Chen China 31 1.5k 2.2× 418 1.1× 362 1.3× 221 0.9× 461 1.9× 167 3.7k
Mingyang Wang China 27 1.2k 1.7× 212 0.6× 343 1.2× 155 0.6× 278 1.2× 141 2.3k
Seong‐Hoon Park South Korea 27 1.9k 2.8× 294 0.8× 464 1.7× 292 1.2× 493 2.1× 142 4.4k
Ji‐Min Cao China 25 1.1k 1.6× 213 0.6× 215 0.8× 103 0.4× 140 0.6× 86 2.9k
Wei Meng China 22 822 1.2× 274 0.7× 198 0.7× 122 0.5× 161 0.7× 113 1.6k

Countries citing papers authored by Xiaodan Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaodan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodan Xu more than expected).

Fields of papers citing papers by Xiaodan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodan Xu. The network helps show where Xiaodan Xu may publish in the future.

Co-authorship network of co-authors of Xiaodan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodan Xu. A scholar is included among the top collaborators of Xiaodan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodan Xu. Xiaodan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Huanhuan, Xiaojun Zhang, Xiaodan Xu, et al.. (2025). Comparison of 64Cu-DOTA-PSMA-3Q and 64Cu-NOTA-PSMA-3Q utilizing NOTA and DOTA as bifunctional chelators in prostate cancer: preclinical assessment and preliminary clinical PET/CT imaging. European Journal of Nuclear Medicine and Molecular Imaging. 52(8). 2792–2803. 2 indexed citations
2.
Liu, Huanhuan, Guangyu Ma, Xiaodan Xu, et al.. (2025). Head-to-Head comparison of [18F]AlF-NOTA-TATE and [68Ga]Ga-DOTA-TATE PET/CT in patients with neuroendocrine tumors: a prospective study. European Journal of Nuclear Medicine and Molecular Imaging. 53(3). 1608–1619. 1 indexed citations
3.
Xu, Xiaodan, et al.. (2024). Berberine: A multifaceted agent for lung cancer treatment-from molecular insight to clinical applications. Gene. 934. 149021–149021. 3 indexed citations
4.
Zhang, Zihao, et al.. (2024). Establishing an AI model and application for automated capsule endoscopy recognition based on convolutional neural networks (with video). BMC Gastroenterology. 24(1). 394–394. 1 indexed citations
5.
Yin, Minyue, et al.. (2024). Automated machine learning for early prediction of acute kidney injury in acute pancreatitis. BMC Medical Informatics and Decision Making. 24(1). 16–16. 7 indexed citations
6.
Tiemann, Michael, et al.. (2024). Electrochemical Removal of HF from Carbonate-based LiPF6-containing Li-ion Battery Electrolytes. Journal of The Electrochemical Society. 171(3). 30522–30522. 3 indexed citations
7.
Niu, Shaoxi, Xiaojun Zhang, Huanhuan Liu, et al.. (2024). Real-time diagnosis of sampled lesions in targeted biopsy of prostate Cancer using a novel tracer [64Cu] Cu-DOTA-PSMA-3Q: a pilot preclinical study. European Journal of Nuclear Medicine and Molecular Imaging. 52(4). 1257–1270. 3 indexed citations
8.
Han, Yun, Jingfeng Zhang, Jianzhong Cui, et al.. (2024). The value of radiomics based on 2-[18 F]FDG PET/CT in predicting WHO/ISUP grade of clear cell renal cell carcinoma. EJNMMI Research. 14(1). 5 indexed citations
9.
Zhang, Wenwen, Zhanbo Wang, Jiajin Liu, et al.. (2023). The role of 18F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy. Frontiers in Immunology. 14. 1151967–1151967. 3 indexed citations
10.
Ye, Ye, et al.. (2023). Survival analysis of extragastrointestinal stromal tumors based on the SEER database: a population-based study. Surgical Endoscopy. 37(11). 8498–8510. 5 indexed citations
11.
Zhang, Wei, Dongdong Li, Xiaodan Xu, et al.. (2023). A Bispecific Peptide‐Polymer Conjugate Bridging Target‐Effector Cells to Enhance Immunotherapy. Advanced Healthcare Materials. 12(18). e2202977–e2202977. 12 indexed citations
12.
Yuan, Wen, et al.. (2023). Reciprocal Links Between Friendship Quality and Peer Victimization Among Middle Adolescents. Journal of Interpersonal Violence. 39(9-10). 2127–2147. 2 indexed citations
13.
Shi, Xueying, Bing Xiao, Xiaodan Xu, et al.. (2023). Combination of Cryo‐Shocked M1 Macrophages and Lonidamine Nanodrugs Enables Potent Chemo‐Immunotherapy. Advanced Functional Materials. 34(2). 10 indexed citations
15.
Xu, Xiaodan, Xueting Wang, Li Zhao, et al.. (2023). Development and post-Kasai procedure prognostic relevance of histological features for biliary atresia. BMC Pediatrics. 23(1). 589–589. 4 indexed citations
16.
Zhou, Kewen, et al.. (2022). Acetylcholine suppresses LPS-induced endothelial cell activation by inhibiting the MAPK and NF-κB pathways. European Cytokine Network. 33(4). 79–89. 3 indexed citations
17.
Li, Ming, Xiaodan Xu, Kaijian Xia, et al.. (2021). Comparison of Diagnostic Performance between Perfusion-Related Intravoxel Incoherent Motion DWI and Dynamic Contrast-Enhanced MRI in Rectal Cancer. Computational and Mathematical Methods in Medicine. 2021. 1–7. 5 indexed citations
18.
Li, Ming, Xiaodan Xu, Pengjiang Qian, et al.. (2021). Texture Analysis in the Assessment of Rectal Cancer: Comparison of T2WI and Diffusion-Weighted Imaging. Computational and Mathematical Methods in Medicine. 2021. 1–7. 3 indexed citations
19.
Liao, Zhenyu, Lianghai Wang, Yuan Liao, et al.. (2021). A combination of pirfenidone and TGF-β inhibition mitigates cystic echinococcosis-associated hepatic injury. Parasitology. 148(7). 767–778. 7 indexed citations
20.
Xu, Xiaodan. (2014). New index to predict esophageal variceal bleeding in cirrhotic patients. World Journal of Gastroenterology. 20(22). 6989–6989. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026